Axel Lechner
Impact in
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cancer Cells and Metastasis
- Immunology top 10%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immune cells in cancer
Papers in
- Oncology 17
- Cancer Immunotherapy and Biomarkers 11
- Cancer Cells and Metastasis 5
- CAR-T cell therapy research 2
- Immunology 11
- Immune Cell Function and Interaction 6
- Immunotherapy and Immune Responses 6
- Immune cells in cancer 2
- Co-authors
- Alexander Quaas (9 shared papers)Martin Thelen (8 shared papers)Hans Schlößer (7 shared papers)Kerstin Wennhold (7 shared papers)Dirk Beutner (7 shared papers)Michael von Bergwelt‐Baildon (7 shared papers)María A. García-Márquez (6 shared papers)Alexander Shimabukuro‐Vornhagen (5 shared papers)
- Journals
- OncoImmunology (2 papers)Cancer Immunology Immunotherapy (2 papers)Cancer Immunology Research (2 papers)Journal of Clinical Oncology (1 paper)Journal of Personalized Medicine (1 paper)
- Partner nations
- GermanySwitzerlandUnited Kingdom
In The Last Decade
Axel Lechner
26 papers receiving 668 citations
Peers
Comparison fields: 5 of 63
- Oncology 362
- Immunology 289
- Otorhinolaryngology 49
- Hepatology 40
- Cancer Research 65
Countries citing papers authored by Axel Lechner
This map shows the geographic impact of Axel Lechner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Axel Lechner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Axel Lechner more than expected).
Fields of papers citing papers by Axel Lechner
This network shows the impact of papers produced by Axel Lechner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Axel Lechner. The network helps show where Axel Lechner may publish in the future.
Co-authors
The 25 scholars most cited alongside Axel Lechner, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2019 | 116 | |
| 2 | 2020 | 108 | |
| 3 | 2017 | 94 | |
| 4 | 2021 | 68 | |
| 5 | 2018 | 55 | |
| 6 | 2017 | 48 | |
| 7 | 2017 | 29 | |
| 8 | 2018 | 27 | |
| 9 | 2018 | 23 | |
| 10 | 2012 | 19 | |
| 11 | 2017 | 15 | |
| 12 | 2021 | 12 | |
| 13 | 2021 | 11 | |
| 14 | 2013 | 11 | |
| 15 | 2021 | 10 | |
| 16 | 2021 | 9 | |
| 17 | 2021 | 4 | |
| 18 | 2021 | 4 | |
| 19 | 2012 | 3 | |
| 20 | 2022 | 2 |
About Axel Lechner
Axel Lechner is a scholar working on Oncology, Immunology, Otorhinolaryngology, Molecular Biology and Cancer Research, having authored 29 papers that have together received 674 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (11 papers), Immune Cell Function and Interaction (6 papers), Immunotherapy and Immune Responses (6 papers), Head and Neck Cancer Studies (5 papers), Cancer Cells and Metastasis (5 papers), Cancer Genomics and Diagnostics (2 papers), Immune cells in cancer (2 papers) and CAR-T cell therapy research (2 papers). The work is most often cited by research in Oncology (362 citations), Immunology (289 citations), Otorhinolaryngology (49 citations), Hepatology (40 citations) and Cancer Research (65 citations). Axel Lechner has collaborated with scholars based in Germany, Switzerland and United Kingdom. Frequent co-authors include Alexander Quaas, Martin Thelen, Hans Schlößer, Kerstin Wennhold, Dirk Beutner, Michael von Bergwelt‐Baildon, María A. García-Márquez, Alexander Shimabukuro‐Vornhagen, Sacha I. Rothschild and Christian U. Huebbers. Their work appears in journals such as OncoImmunology, Cancer Immunology Immunotherapy, Cancer Immunology Research, Journal of Clinical Oncology and Journal of Personalized Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.